Study shows underlying connection between 'good' cholesterol and collagen in heart health

November 1, 2012 in Cardiology

Softening arteries, protecting the heart

Enlarge

This image shows collagen production (stained red) in aortic smooth muscle cells. The cell nuclei are stained blue. Credit: Richard K. Assoian, Ph.D., Perelman School of Medicine, Univeristy of Pennsylvania; Cell Reports

(Medical Xpress)—Arterial stiffening has long been considered a major risk factor for cardiovascular disease. Keeping arteries soft and supple might reduce disease risk, but the mechanisms of how arteries stave off hardening has remained elusive.

Researchers from the Perelman School of Medicine, University of Pennsylvania, Wistar Institute, and The Children's Hospital of Philadelphia have discovered that the protein apolipoprotein E (apoE) plays a major role in maintaining arterial softness by suppressing production of the , a network of in the body. Their research appeared in the most recent issue of Cell Reports.

ApoE is a component of several , including HDL, the "good" cholesterol, and is generally believed to forestall atherosclerosis. But several recent major studies have questioned the link between HDL and cardiovascular protection. Meanwhile, other research involving has indicated that apoE has effects beyond its role in regulating as a component of HDL. The present work suggests that it may be the apoE-containing HDL that confers the main benefit of HDL by promoting arterial softness.

Analyzing genetic datasets of regular mice and without apoE, the researchers showed definite differences in , with the apoE-null mice displaying marked increase in indicators of stiffening – the proteins collagen, fibronectin, and lysyl oxidase in response to stiffening in the , which led to severe atherosclerosis. To attempt to mitigate the atherosclerosis seen in the apoE-null mice, the researchers fed them a high-fat diet and treated them with a lysyl oxidase inhibitor, which softened their arteries.

Despite highly elevated cholesterol, the mice showed a marked improvement in their atherosclerosis. The results suggest that the lack of apoE results in arterial stiffness, and that even with , increasing arterial elasticity by pharmacologic means can greatly reduce atherosclerotic disease.

"HDL can't be looked at as just one compound, because it is a mixture of different molecular components," explains senior author Richard K. Assoian, PhD, professor of Pharmacology. "The component that has these effects on arterial stiffening is a minor part of total HDL." Assoian notes that this could help to reconcile the conflicting clinical evidence regarding the link between HDL and reduced cardiovascular disease. "It might be the apoE HDL fraction that you need to keep high and not worry about the total HDL," he suggests. Because apoE is only about 6 percent of total HDL, "it could go up sky high or not at all, and you probably wouldn't detect it in these studies that try to raise total HDL."

The possibility of preventing or treating atherosclerosis by promoting arterial elasticity independent of cholesterol could be a boon for the many people unable to tolerate the statin drugs that are the usual treatment.

"Perhaps there are other routes that you could use, independent of cholesterol and statins, that could help keep atherosclerosis at bay," says co-first author Devashish Kothapalli, PhD. "We think controlling stiffening is one of those. We showed in the paper that even when cholesterol is remarkably high, if you soften tissues back to a healthy level, atherosclerosis is inhibited."

Targeting arterial stiffening could also provide added benefit for patients already on statins. "Ultimately we would hope that controlling stiffening could be used in conjunction with a statin for the large percentage of people who are already on statins but need extra help," says co-first author Shu-Lin Liu, PhD.

Although the current study demonstrates how apoE and apoE-containing HDL promote cardiovascular health by maintaining arterial softness, Assoian notes that a practical treatment would likely not target apoE, because it "does a lot of other things that you don't want to interfere with. So the goal in my mind would be to develop something that is really targeting stiffness but not affecting any of the lipid aspects of that apoE and HDL control. The lysyl oxidase inhibitor drug we used in this study, BAPN, is good for proof of principle, but not useful on a practical level, because there are too many side effects."

More information: download.cell.com/… 12003221.pdf

Journal reference: Cell Reports search and more info website

Provided by University of Pennsylvania School of Medicine search and more info website

4 /5 (3 votes)  

Rank 4 /5 (3 votes)
Relevant PhysicsForums posts

More news stories

Heart failure accelerates male 'menopause'

Heart failure accelerates the aging process and brings on early andropausal syndrome (AS), according to research presented today at the Heart Failure Congress 2013. AS, also referred to as male 'menopause', was four times ...

Cardiology created 5 hours ago | popularity not rated yet | comments 1

Death highest in heart failure patients admitted in January, on Friday, and overnight

Mortality and length of stay are highest in heart failure patients admitted in January, on Friday, and overnight, according to research presented today at the Heart Failure Congress 2013. The analysis of nearly 1 million ...

Cardiology created 5 hours ago | popularity not rated yet | comments 0

First drug to improve heart failure mortality in over a decade

Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented today at Heart Failure 2013 congress. It is the first drug to improve heart failure mortality ...

Cardiology created 5 hours ago | popularity 5 / 5 (1) | comments 4

Registry confirms TAVI efficacy and safety in Asian patients

Transcatheter aortic valve implantation (TAVI) is effective and safe in Asian patients, according to early experience based on first results from a multicentre Asian registry reported at EuroPCR 2013.

Cardiology created May 24, 2013 | popularity not rated yet | comments 0

Diagnostic coronary angiography: Functional flow reserve changes decisions in 25 percent of cases

Routinely measuring fractional flow reserve (FFR) using pressure wire assessment during coronary angiography for diagnosis of chest pain leads to significant changes in the management of one in four patients, according to ...

Cardiology created May 24, 2013 | popularity not rated yet | comments 0


Feds fight morning-after pill age ruling in NY

(AP)—Department of Justice lawyers have again asked a federal appeals court in New York to delay lifting age restrictions and prescription requirements on an emergency contraceptive popularly known as the morning-after ...

Researchers identify first drug targets in childhood genetic tumor disorder

Two mutations central to the development of infantile myofibromatosis (IM)—a disorder characterized by multiple tumors involving the skin, bone, and soft tissue—may provide new therapeutic targets, according to researchers ...

Driving and hands-free talking lead to spike in errors, study shows

Talking on a hands-free device while behind the wheel can lead to a sharp increase in errors that could imperil other drivers on the road, according to new research from the University of Alberta.

Comorbidities common with alopecia areata

(HealthDay)—Comorbid conditions often accompany alopecia areata, according to a study published online May 22 in JAMA Dermatology.

Pollen count apps for smartphones are nothing to sneeze at

Kate O'Reilly's spring allergy survival kit includes the usual stuff - nasal sprays, allergy pills and a box of tissues. This season, she's added a new weapon to her line of defense: an app on her smartphone.

Storm chasers: born to be wild?

(HealthDay)—We've all seen them: the surfers who race to the beach when a hurricane hits, the guy who decides to ride out the storm in his overmatched boat, the tornado chasers who fearlessly steer their ...